• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed

    2/9/21 4:32:11 PM ET
    $NTN
    Broadcasting
    Consumer Services
    Get the next $NTN alert in real time by email
    8-K 1 form8-k.htm

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the

    Securities Exchange Act of 1934

     

    Date of report (Date of earliest event reported): February 9, 2021

     

    NTN BUZZTIME, INC.

    (Exact name of registrant as specified in charter)

     

    Delaware   001-11460   31-1103425

    (State or other jurisdiction of

    incorporation)

     

    (Commission

    File Number)

     

    (I.R.S. Employer

    Identification No.)

     

    6965 El Camino Real, Suite 105-Box 517    
    Carlsbad, California   92009
    (Address of principal executive offices)   (Zip Code)

     

    (760) 438-7400

    (Registrant’s telephone number, including area code)

     

    Not Applicable

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    [X] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    [  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    [  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    [  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock   NTN   NYSE American

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company [  ]

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.[  ]

     

     

     

     

     

     

    Item 8.01 Other Events.

     

    On February 9, 2021, Brooklyn ImmunoTherapeutics LLC (“Brooklyn”) issued a press release announcing, among other matters, the initiation of an open-label Phase 2 clinical trial of IRX-2 in combination with pembrolizumab (Keytruda®) and chemotherapy in triple negative breast cancer (TNBC). A copy of the press release is attached as an exhibit to this report and is incorporated herein by reference.

     

    As previously announced, on August 12, 2020, NTN Buzztime, Inc. (“NTN”) entered into an Agreement and Plan of Merger and Reorganization with Brooklyn and BIT Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of NTN (“Merger Sub”), pursuant to which, subject to the satisfaction of the conditions to closing, Merger Sub will be merged with and into Brooklyn, with Brooklyn surviving the merger as a wholly-owned subsidiary of NTN. NTN will be holding its special meeting of stockholders to consider the merger, and the proposed sale of NTN’s assets to eGames.com Holdings LLC (“eGames.com”) and related proposals on March 15, 2021 at 9:00 a.m., Pacific Time, unless postponed or adjourned to a later date or time. Additional details regarding the proposals and the special meeting are available in the proxy statement/prospectus/consent solicitation statement relating to the special meeting that was filed with the Securities and Exchange Commission on February 8, 2021.

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits

     

    Exhibit No.   Description
    99.1   Press release issued by Brooklyn ImmunoTherapeutics LLC dated February 9, 2021

     

    *       *      *

     

    No Offer or Solicitation

     

    This release is not intended to and shall not constitute an offer to sell or the solicitation of an offer to buy any securities or the solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities in connection with the proposed merger contemplated by the agreement and plan of merger and reorganization between NTN and Brooklyn dated August 12, 2020 shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

     

    Additional Information and Where to Find It

     

    In connection with the proposed merger and asset sale, NTN filed relevant materials with the SEC, including a registration statement on Form S-4, that will serve as a proxy statement and prospectus of NTN and a consent solicitation statement for the beneficial holders of Brooklyn’s Class A membership units, and will be mailed or otherwise disseminated to NTN stockholders and to the beneficial holders of Brooklyn’s Class A membership units if and when it becomes available. INVESTORS AND SECURITY HOLDERS OF NTN AND BROOKLYN ARE URGED TO READ THESE MATERIALS CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT NTN, BROOKLYN, THE PROPOSED MERGER AND ASSET SALE, AND RELATED MATTERS. The proxy statement/prospectus/consent solicitation statement and other relevant materials (when they become available) and any other documents filed by NTN with the SEC, may be obtained free of charge at the SEC website at www.sec.gov. In addition, investors and security holders may obtain free copies of the documents filed with the SEC by NTN by directing a written request to: NTN Buzztime, Inc, 6965 El Camino Real, Suite 105-Box 517, Carlsbad, California 92009. Investors and security holders are urged to read the proxy statement/prospectus/consent solicitation statement and the other relevant materials when they become available before making any voting or investment decision with respect to the proposed merger and asset sale.

     

     

     

     

    Participants in the Solicitation

     

    NTN and its directors, executive officers and certain other members of management and employees, Brooklyn and its managers and officers, and eGames.com and its managers and officers may, under SEC rules, be deemed to be participants in the solicitation of proxies from the stockholders of NTN with respect to the proposed merger and asset sale and related matters. Information about the directors and executive officers of NTN, including their ownership of shares of common stock is set forth in NTN’s Annual Report on Form 10-K for the year ended December 31, 2019 and Amendment No. 1 thereto, which were filed with the SEC on March 19, 2020 and April 27, 2020, respectively (the “2019 Annual Report”). Additional information regarding the persons or entities who may be deemed participants in the solicitation of proxies from NTN stockholders, including a description of their interests in the proposed merger and asset sale, by security holdings or otherwise, are included in the proxy statement/prospectus/consent solicitation statement referred to above and other relevant documents to be filed with the SEC when they become available. As described above, these documents will be available free of charge at the SEC’s website or by directing a written request to NTN. Neither the managers or officers of Brooklyn nor the managers or officers of eGames.com currently hold any interests, by security holdings or otherwise, in NTN.

     

    Forward-Looking Statements

     

    This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are any statements that are not statements of historical fact and may be identified by terminology such as “expect,” “intend,” “plan,” “believe,” “anticipate,” “may,” “will,” “would,” “should,” “could,” “contemplate,” “estimate,” “predict,” “potential” or “continue,” or the negative of these terms or other similar words. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those stated or implied in any forward-looking statement as a result of various factors, including, but not limited to: (i) risks that the conditions to the closing of the proposed merger and/or asset sale are not satisfied, including the failure of NTN and Brooklyn to timely obtain the requisite stockholder and member approvals for the merger and/or asset sale and related matters or to meet the net cash and capitalization requirements under the merger agreement, as applicable; (ii) uncertainties as to the timing of the consummation of the proposed merger and asset sale and the ability of each party to consummate the proposed merger and asset sale; (iii) risks related to NTN’s and Brooklyn’s ability to manage their respective operating expenses and expenses associated with the proposed merger and asset sale, as applicable, pending closing of the merger; (iv) the risk that, as a result of adjustments to the exchange ratio, NTN stockholders and Brooklyn members could own more or less of the combined company than is currently anticipated; (v) NTN’s continued listing on the NYSE American; (vi) uncertainties related to the impact of the COVID-19 pandemic on the business and financial condition of NTN, Brooklyn and the combined company and the ability of NTN and Brooklyn to consummate the merger and NTN and eGames.com to consummate the asset sale; (vii) NTN’s ability to continue to operate as a going concern if the proposed merger or asset sale are not consummated in a timely manner, or at all; (viii) Brooklyn’s need for, and the availability of, substantial capital in the future to fund its operations and research and development activities; (ix) Brooklyn’s ability to successfully progress research and development efforts after the merger, including its manufacturing development efforts, and to create effective, commercially-viable products; (x) the success of Brooklyn’s product candidates in completing pre-clinical or clinical testing and being granted regulatory approval to be sold and marketed in the United States or elsewhere; (xi) the outcome of any legal proceedings that have been instituted against NTN, Brooklyn, eGames.com or others related to the merger agreement or the asset purchase agreement, as applicable; (xii) the occurrence of any event, change or other circumstance or condition that could give rise to the termination of either or both of those agreements; (xiii) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed merger or asset sale; and (xiv) those risks and uncertainties discussed in NTN’s reports filed with the SEC, including its 2019 Annual Report, its Quarterly Reports on Form 10-Q and its Current Reports on Form 8-K, as well as other documents that may be filed by NTN from time to time with the SEC available at www.sec.gov.

     

    You should not rely upon forward-looking statements as predictions of future events. NTN cannot assure you that the events and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results could differ materially from those projected in the forward-looking statements. The forward-looking statements made in this communication speak only as of the date on which they were made. NTN does not undertake any obligation to update the forward-looking statements contained herein to reflect events that occur or circumstances that exist after the date hereof, except as may be required by applicable law or regulation.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      NTN BUZZTIME, INC.
       
    Date: February 9, 2021 By: /s/ Sandra Gurrola
        Sandra Gurrola
        Sr. Vice President of Finance

     

     

     

    Get the next $NTN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NTN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NTN
    Financials

    Live finance-specific insights

    See more
    • Ault Global Holdings Acquires 9.96% Equity Interest in NTN Buzztime

      LAS VEGAS--(BUSINESS WIRE)--Ault Global Holdings, Inc. (NYSE American: DPW), a diversified holding company (the “Company”), announced that as of January 29, 2021, the Company had purchased an aggregate of 295,000 shares of common stock or 9.96% equity interest in NTN Buzztime, Inc. (NYSE American: NTN) (“NTN”). The Company purchased the shares of common stock at a weighted average price of $3.42 per share in the open market, for total gross proceeds of $1,010,095. For further information, see the Schedule 13D filed by the Company on January 29, 2021. Milton “Todd” Ault, III, the Executive Chairman of the Company, stated, “We believe NTN’s assets, particularly its gaming assets an

      2/18/21 6:30:00 AM ET
      $NTN
      $DPW
      Broadcasting
      Consumer Services
      Industrial Machinery/Components
      Capital Goods

    $NTN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed

      SC 13G - NTN BUZZTIME INC (0000748592) (Subject)

      2/16/21 5:18:08 PM ET
      $NTN
      Broadcasting
      Consumer Services
    • SEC Form SC 13G/A filed

      SC 13G/A - NTN BUZZTIME INC (0000748592) (Subject)

      2/12/21 1:37:55 PM ET
      $NTN
      Broadcasting
      Consumer Services

    $NTN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • NTN Buzztime Announces Proposed Reverse Stock Split Ratio and Anticipated Closing of Merger

      CARLSBAD, Calif., March 23, 2021 /PRNewswire/ -- NTN Buzztime, Inc. (NYSE American: NTN) today announced that it plans to effect a one for two reverse stock split of its outstanding shares of common stock immediately prior to the closing of the merger with Brooklyn ImmunoTherapeutics LLC, which is anticipated to occur on March 25, 2021. The shares of common stock of the resulting company is expected to commence trading on March 26, 2021 on the NYSE American under the trading symbol "BTX". As previously announced, at special meeting of stockholders of NTN held on March 15, 2021, NTN's stockholders approved, among other proposals, the issuance of shares of NTN's common stock to the members of

      3/23/21 5:25:00 PM ET
      $NTN
      Broadcasting
      Consumer Services
    • NTN Buzztime Announces Approval of Merger with Brooklyn ImmunoTherapeutics by Stockholders at Special Meeting

      CARLSBAD, Calif., March 15, 2021 /PRNewswire/ -- NTN Buzztime, Inc. (NYSE American: NTN) today announced that its stockholders have approved the proposed merger between NTN and Brooklyn ImmunoTherapeutics LLC. The proposed merger remains subject to further customary closing conditions and regulatory approvals. NTN expects that the merger will close in the next two weeks. NTN reported that at the meeting, the following proposals were approved: (i) Proposal 1, relating to the issuance of shares of NTN's common stock to the members of Brooklyn pursuant to the merger and the change of control resulting therefrom, (ii) Proposal 2, authorizing an amendment to NTN's certificate of incorporation to

      3/15/21 7:31:00 PM ET
      $NTN
      Broadcasting
      Consumer Services
    • Independent Advisory Firm ISS Recommends NTN Stockholders Vote FOR Proposed Merger and Asset Sale and ALL Related Proposals

      CARLSBAD, Calif., March 8, 2021 /PRNewswire/ -- NTN Buzztime, Inc. (NYSE American: NTN) today announced that leading independent proxy advisory firm Institutional Shareholder Services, Inc. ("ISS") recommends that NTN stockholders vote "FOR" ALL PROPOSALS to be considered and voted on at the March 15, 2021 special meeting of stockholders, all of which relate to the proposed merger involving NTN and Brooklyn ImmunoTherapeutics LLC ("Brooklyn") and the proposed sale of NTN's assets to eGames.com Holdings LLC ("eGames.com"). "We are very pleased that ISS supports our board's recommendation that stockholders vote "FOR" the proposals related to the merger and asset sale," said Allen Wolff, NTN's

      3/8/21 7:00:00 AM ET
      $NTN
      Broadcasting
      Consumer Services

    $NTN
    SEC Filings

    See more
    • NTN Buzztime, Inc. filed SEC Form 8-K: Completion Of Acquisition Or Disposition Of Assets, Material Modification To Rights Of Security Holders, Changes In Control Of Registrant, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Other Events, Financial Statements And Exhibits

      8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)

      3/31/21 5:18:33 PM ET
      $NTN
      Broadcasting
      Consumer Services
    • SEC Form 8-K filed by NTN Buzztime, Inc.

      8-K - NTN BUZZTIME INC (0000748592) (Filer)

      3/23/21 5:28:45 PM ET
      $NTN
      Broadcasting
      Consumer Services
    • SEC Form 10-K filed

      10-K - NTN BUZZTIME INC (0000748592) (Filer)

      3/11/21 5:07:49 PM ET
      $NTN
      Broadcasting
      Consumer Services

    $NTN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Allen Wolff disposed of $26,550 worth of Common Stock (9,944 units at $2.67), decreasing direct ownership by 7% to 128,520 units

      4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)

      3/26/21 9:54:22 PM ET
      $NTN
      Broadcasting
      Consumer Services
    • SEC Form 4: M Sandra Gurrola disposed of $16,271 worth of Common Stock (6,094 units at $2.67), decreasing direct ownership by 22% to 21,617 units

      4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)

      3/26/21 9:53:07 PM ET
      $NTN
      Broadcasting
      Consumer Services
    • SEC Form 4: M Sandra Gurrola disposed of $409 worth of Common Stock (116 units at $3.53), decreasing direct ownership by 0.42% to 27,711 units

      4 - NTN BUZZTIME INC (0000748592) (Issuer)

      3/22/21 7:00:15 PM ET
      $NTN
      Broadcasting
      Consumer Services